Agilent Technologies (A) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Agilent Technologies in August 2026.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Agilent's stock with a target price of $154.69, indicating growth potential.
Financial Health
Agilent Technologies is showing strong revenue and cash flow, indicating solid financial performance.
Dividend
Agilent Technologies has a low dividend yield of 0.42%, making it less attractive for dividend-seeking investors. If you invested $1000 you would be paid $4.20 a year in dividends (based on the last 12 months).
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.